EV Research Leader HansaBioMed Life Sciences specializes in exosomes, extracellular vesicles (EVs) and nanoparticles with over 15 years of experience, presenting a clear value proposition for collaborations and service-driven sales in EV isolation, characterization, and biomarker analysis.

Part of Exosomics As part of the Exosomics group since 2019, there is potential to leverage cross-company partnerships, bundled offerings, and joint go-to-market strategies to expand diagnostics-focused EV solutions.

Global Collaborations Active collaboration with international academic and industrial research groups signals readiness to engage in multi-site projects and large-scale research partnerships that could drive repeat business for services and high-value products.

Limited Revenue Scale With revenue under $1M and a small team (11-50 employees), opportunities exist to upsell scalable EV purification, bulk characterization, and biomarker workflows to larger labs and contract research organizations seeking niche EV expertise.

Near-term Expansion Potential Recent collaborations such as BioNavis showcase interest in advanced analytics (e.g., MP-SPR) complementary to ExoTEST ELISA, suggesting cross-sell of diagnostics-oriented platforms and integration services for EV research pipelines.